Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Jan-21 6:21 PM View:  | Viking Therapeutics, Inc. (VKTX) | 19-Jan-21 | Payment of Exercise | 1,685 | $6.68 | $11,255.80 | (1%) 117.75K to 116.06K | 3% |
| 06-Jan-21 4:37 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-21 | Grant | 21,334 | -- | -- | 22% 99.15K to 120.49K | |
| 06-Jan-21 4:37 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-21 | Payment of Exercise | 2,739 | $5.80 | $15,886.20 | (2%) 120.49K to 117.75K | |
| 16-Sep-20 5:21 PM View: | Viking Therapeutics, Inc. (VKTX) | 15-Sep-20 | Grant | 4,500 | -- | -- | 5% 94.93K to 99.43K | |
| 16-Sep-20 5:21 PM View: | Viking Therapeutics, Inc. (VKTX) | 15-Sep-20 | Payment of Exercise | 1,557 | $6.25 | $9,731.25 | (2%) 99.43K to 97.87K | < 1% |
| 21-Jan-20 5:35 PM View: | Viking Therapeutics, Inc. (VKTX) | 19-Jan-20 | Payment of Exercise | 2,044 | $7.18 | $14,675.90 | (2%) 94.88K to 92.84K | 14% |
| 22-Jan-19 7:13 PM View: | Viking Therapeutics, Inc. (VKTX) | 19-Jan-19 | Payment of Exercise | 2,044 | $8.78 | $17,946.30 | (2%) 94.03K to 91.99K | 30% |
| 31-May-18 7:03 PM View: | Viking Therapeutics, Inc. (VKTX) | 31-May-18 | Market Sale | 21,551 | $9.25 | $199,347.00 | (19%) 115.59K to 94.03K | 33% |
| 08-May-18 8:37 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-May-18 | Payment of Exercise | 7,616 | $4.22 | $32,139.50 | (7%) 101.65K to 94.03K | (46%) |
| 23-Jan-18 5:42 PM View: | Viking Therapeutics, Inc. (VKTX) | 19-Jan-18 | Grant | 15,000 | -- | -- | 17% 86.65K to 101.65K | |
| 05-May-17 6:25 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-May-17 | Payment of Exercise | 8,192 | $1.34 | $10,977.30 | (9%) 88.8K to 80.6K | (364%) |
| 06-May-15 7:20 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-May-15 | Grant | 67,000 | -- | -- | 100% 0 to 67.0K | |
| 06-May-15 7:20 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-May-15 | Payment of Exercise | 10,404 | $9.49 | $98,734.00 | 16% 67.0K to 77.4K | |
| 13-Sep-13 7:14 PM View: | Trius Therapeutics Inc (TSRX) | 11-Sep-13 | Disposition | 14,070 | -- | -- | (100%) 14.07K to 0 | |
| 12-Jul-13 6:56 PM View: | Trius Therapeutics Inc (TSRX) | 11-Jul-13 | Option Exercise | 20,000 | $4.00 | $80,000.00 | 159% 12.54K to 32.55K | |
| 12-Jul-13 6:56 PM View: | Trius Therapeutics Inc (TSRX) | 11-Jul-13 | Market Option Sale (Planned) | 20,000 | $9.75 | $195,000.00 | (61%) 32.55K to 12.54K | (40%) |
| 16-May-13 2:41 PM View: | Trius Therapeutics Inc (TSRX) | 14-May-13 | Option Exercise | 20,000 | $4.00 | $80,000.00 | 188% 10.63K to 30.64K | |
| 16-May-13 2:41 PM View: | Trius Therapeutics Inc (TSRX) | 14-May-13 | Market Option Sale (Planned) | 20,000 | $7.75 | $155,000.00 | (65%) 30.64K to 10.63K | (76%) |